SF3A2 and neoplasm: Using four independent computational algorithms (TIMER, EPIC, QUANTISEQ, and MCPCOUNTER), we consistently demonstrated that high SF3A2 expression was associated with markedly reduced infiltration levels of multiple anti-tumor immune cell subsets, including CD8+ T cells, dendritic cells, and M1 macrophages.